SCHEMBL31455508

SCHEMBL31455508

Cc1cc([N+](=O)[O-])c(Nc2ccc(C3CN(C(=O)OC(C)(C)C)C3)cc2)nc1Cl

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
IGF1R P08069 1/20 0.39
SLC34A1 Q06495 1/20 0.39
MAPT P10636 2/20 0.38
ALDH1A1 P00352 1/20 0.38
NPY1R P25929 1/20 0.38
NPY2R P49146 1/20 0.38
RAB9A P51151 1/20 0.38
JAK3 P52333 3/20 0.38
LCK P06239 2/20 0.38
BTK Q06187 1/20 0.38
POLB P06746 1/20 0.38
MAPK1 P28482 1/20 0.38
CCNK O75909 1/20 0.37
CCNA2 P20248 1/20 0.37
CDK2 P24941 1/20 0.37
CCND3 P30281 1/20 0.37
CDK9 P50750 1/20 0.37
CDK6 Q00534 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31455299 0.88 SLC34A1 (0.40) IGF1RSLC34A1JAK3LCKBTK
SCHEMBL31455504 0.83 MKNK1 (0.40) MEN1KMT2AIGF1RMAPTALDH1A1
SCHEMBL31454988 0.81 MAPK1 (0.43) SLC34A1MAPTJAK3LCKBTK
SCHEMBL31420326 0.80 NAMPT (0.40) JAK3LCKBTKGPR119NAMPT
SCHEMBL31455683 0.78 JAK2 (0.46) SLC34A1JAK3LCKBTK
SCHEMBL19175230 0.76 LMNA (0.44) MEN1KMT2AMAPTALDH1A1RAB9A
SCHEMBL31455485 0.76 ALDH1A1 (0.44) MEN1KMT2AMAPTALDH1A1RAB9A
SCHEMBL31455266 0.76 USP30 (0.41) IGF1RSLC34A1MAPTALDH1A1MKNK1
SCHEMBL31455102 0.74 NAMPT (0.45) IGF1RJAK3LCKBTKGPR119
SCHEMBL31455018 0.73 SLC34A1 (0.42) IGF1RSLC34A1JAK3LCKBTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025059577-A1 SUBSTITUTED AMINOPYRIDINE COMPOUNDS FOR USE AS AKT1 INHIBITORS ATAVISTIK BIO, INC. (US) 2025-03-20 WO disclosed